Ballout Farah, Daouk Reem, Azar Joseph, Timonian Michael, Araji Tarek, Bahmad Hisham F, Abou-Kheir Wassim
Department of Anatomy, Cell Biology, and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, 4300 Alton Rd, Miami Beach, FL 33140 USA.
SN Compr Clin Med. 2020;2(11):2005-2014. doi: 10.1007/s42399-020-00549-w. Epub 2020 Sep 30.
Coronavirus disease 2019 (COVID-19) has infected millions of people worldwide and emerged to be the biggest global health threat claiming hundreds of thousands of lives at exponential rates. The severity of the disease increases with old age and presence of underlying health conditions, such as cancer. Managing cancer patients under these circumstances is rather challenging, given their compromised immunity and the overwhelmed health care services by COVID-19 community transmission. Thus, it is prudent to establish common guidelines for the monitoring and treatment of cancer patients. In this review, we comprehensively investigate the various aspects of cancer care during the COVID-19 pandemic, discuss challenges faced while treating cancer patients, and propose potential approaches to manage COVID-19 among this vulnerable population. We also discuss molecular aberrations and genetic changes associated with cancer and their role in affecting the virus' infectivity and severity. Lastly, we shed light on therapeutic approaches that can encompass both diseases without compromising one over the other.
2019冠状病毒病(COVID-19)已在全球感染了数百万人,并成为最大的全球健康威胁,正以指数级速度夺走数十万人的生命。该疾病的严重程度随着年龄增长以及诸如癌症等潜在健康状况的存在而增加。在这种情况下管理癌症患者颇具挑战性,因为他们的免疫力受损,且COVID-19的社区传播使医疗服务不堪重负。因此,制定癌症患者监测和治疗的通用指南是审慎之举。在本综述中,我们全面研究了COVID-19大流行期间癌症护理的各个方面,讨论了治疗癌症患者时面临的挑战,并提出了在这一弱势群体中管理COVID-19的潜在方法。我们还讨论了与癌症相关的分子畸变和基因变化及其在影响病毒传染性和严重程度方面的作用。最后,我们阐明了能够兼顾两种疾病而不偏袒任何一方的治疗方法。